Objective To provide updated guidelines for pharmacologic management of juvenile
idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint …

Abstract Purpose of Review To summarize the current evidence on the adoption of the treat-
to-target (T2T) strategy in pediatric rheumatic diseases (PRD). Recent Findings The recent …

Enthesitis-related arthritis (ERA) is a category of juvenile idiopathic arthritis which belongs to
the spectrum of diseases that are included in juvenile spondyloarthropathy. In recent years …

Arthritis affects persons of all ages, including younger adults, adolescents, and children;
however, recent arthritis prevalence estimates among children and adolescents aged< 18 …

Clinical practice guidelines (CPGs) are developed to ensure that the treating physician has
the exposure to the best evidence-based practices, which is translated into …

In the past two decades, the treatment of juvenile idiopathic arthritis (JIA) has evolved
markedly, owing to the availability of a growing number of novel, potent and relatively safe …

Uveitis is an ocular inflammatory disease that can lead to visual complications and
permanent vision loss, if not promptly detected and treated [1, 2]. The etiology of uveitis …

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. The
International League of Associations for Rheumatology (ILAR) has defined JIA as “arthritis of …

Over the past decade, imaging of inflammatory arthritis in juvenile arthropathies has
significantly advanced due to technological improvements in the imaging modalities and …

Purpose To assess the efficacy of adalimumab (ADA) on visual acuity (VA), ocular
inflammation, vitreous haze and central macular thickness (CMT) in pediatric refractory non …